Wave 80 Biosciences develops next-generation molecular diagnostics instruments and consumables for hepatitis B, hepatitis C, HIV/AIDS, and other human health conditions. Offering on-demand testing, best-in-class performance, a broad set of assay panels, and a superior value proposition, Wave 80’s pipeline products address unmet needs of diverse patient populations worldwide. Founded in 2003, Wave 80 is headquartered in a 7900 sq. ft. lab/office facility in San Francisco, California, near the Mission Bay campus of the University of California at San Francisco. Wave 80’s talented technical staff encompasses expertise in high-sensitivity molecular assay methods, microfluidics, photonics, user-centered design, design-for-manufacturing, clinical trials design, and compliance with diverse global regulatory regimes.
Wave 80 Biosciences